LEP and central nervous system cancer: To investigate whether targeted inhibition of the Notch signaling pathway could reverse the reported induction of cell proliferation and migration mediated by leptin, we treated cells with a Notch inhibitor (RO4929097, GSI), a potent and selective small molecule inhibitor of gamma-secretase that is currently in phase 1 of clinical trials in patients with glioma [50].